IRS1 and gestational diabetes: Further studies have found that miRNA-7 can regulate MAP kinase signaling by targeting insulin receptor substrate 1/2 (IRS1/2) and RAF1, leading to chronic low-grade inflammation and promoting the progression of GDM [70].